Reported COVID-19 vaccines side effects among Jordanian population: a cross sectional study
Haya Omeish, Angam Najadat, Sayer Al‐Azzam, Nada Tarabin, Amer Abu Hameed, Neebal Al-Gallab, Hadeel Abbas, Lana K Rababah, Majd Rabadi, Reema Karasneh, Mamoon A. Aldeyab
Abstract
< .001). Only one case for each of second dose of Pfizer and Sinopharm vaccines reported that their side effects required hospitalization. In this study, we found that people in Jordan experienced more side effects with AstraZeneca vaccine followed by Pfizer vaccine and the least one is Sinopharm vaccine. Our study showed that these side effects are not severe and should not be an obstacle against the successful control of the pandemic in Jordan.
Topics & Concepts
MedicinemyalgiaNauseaSide effect (computer science)Cross-sectional studyAdverse effectChillsPopulationVaccinationInternal medicineImmunologyEnvironmental healthProgramming languageComputer sciencePathologySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesVaccine Coverage and Hesitancy